Serum Leukocyte Immunoglobulin-Like Receptor A3 (LILRA3) Is Increased in Patients with Multiple Sclerosis and Is a Strong Independent Indicator of Disease Severity; 6.7kbp LILRA3 Gene Deletion Is Not Associated with Diseases Susceptibility

• Hongyan An,

  Affiliation Inflammation and Infection Research Centre, School of Medical Sciences, Department of Pathology, University of New South Wales, Sydney, NSW 2052, Australia

  ⨯
• Chai Lim,

  Affiliation MND and Neurodegenerative diseases Research Centre, Australian School of Advanced Medicine (ASAM), Macquarie University, Sydney, NSW 2109, Australia

  ⨯
• Gilles J. Guillemin,

  Affiliation MND and Neurodegenerative diseases Research Centre, Australian School of Advanced Medicine (ASAM), Macquarie University, Sydney, NSW 2109, Australia

  ⨯
• Ute Vollmer-Conna,

  Affiliation School of Psychiatry, University of New South Wales, Sydney, NSW 2050, Australia

  ⨯
• William Rawlinson,

  Affiliation Department of Virology, South Eastern Sydney and Illawarra Health Service, Prince of Wales Hospital, Sydney, NSW 2032, Australia

  ⨯
• Katherine Bryant,

  Affiliations Inflammation and Infection Research Centre, School of Medical Sciences, Department of Pathology, University of New South Wales, Sydney, NSW 2052, Australia, South Western Sydney Clinical School, University of New South Wales, Sydney, NSW 2170, Australia

  ⨯
• Nicodemus Tedla

  * E-mail: n.tedla@unsw.edu.au

  Affiliation Inflammation and Infection Research Centre, School of Medical Sciences, Department of Pathology, University of New South Wales, Sydney, NSW 2052, Australia

  ⨯